Powder: -20°C for 3 years | In solvent: -80°C for 1 year
IX 207-887 inhibits the release of interleukin-1 (IL-1). IX 207-887 is a novel antiarthritic agent.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
2 mg | 5 days | $ 88.00 |
Description | IX 207-887 inhibits the release of interleukin-1 (IL-1). IX 207-887 is a novel antiarthritic agent. |
In vitro | IX 207-887 is a novel antiarthritic agent that does not impact the adherence of human monocytes nor significantly inhibit IL-1 or IL-2-induced thymocyte proliferation. It shows no IL-1 antagonistic activity in chondrocyte tests. However, IX 207-887 effectively inhibits the release of interleukin-1 (IL-1) from human monocytes and mouse peritoneal macrophages, significantly reducing both biologically active and immunoreactive IL-1 in culture media. The levels of IL-1 in homogenates or lysates remain largely unchanged or are only slightly reduced. |
Molecular Weight | 284.33 |
Formula | C16H12O3S |
CAS No. | 98320-39-9 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
IX 207-887 98320-39-9 Others IX 207 887 IX 207887 inhibitor inhibit